OBJECTIVE: We sought to estimate the rates and types of evaluation in women with atypical
glandular cells of undetermined significance (AGC-US) on cervical cytology and to assess …

OBJECTIVE: To evaluate the prevalence and histologic outcomes of patients with atypical
glandular cells of undetermined significance (AGUS), diagnosed by Pap test, and concurrent …

OBJECTIVE: To estimate the risk of significant pathology from atypical glandular cell (AGC)
Pap tests classified by the 2001 Bethesda system and to assess potential differences in AGC …

Objectives. The aim of this study was to evaluate the efficacy of the follow-up methods and
results of atypical glandular cells of undetermined significance (AGUS) detected on …

Objective: To determine the clinical significance of and underlying pathology among patients
with atypical glandular cells of undetermined significance (AGCUS) identified on cervical …

OBJECTIVES: To estimate the rates of and identify risk factors for disease in women with
atypical glandular cells of undetermined significance (AGUS). METHODS: From 1998–2001 …

Objective. To determine the relationship between history of cervical dysplasia or carcinoma
and the development of cervical dysplasia or adenocarcinoma in women who have a …

OBJECTIVE: Atypical glandular cell (AGC) Pap interpretations and screening for glandular
neoplasias remain major challenges. We document the largest reported AGC …

This article is to determine the clinical significance and underlying pathology among patients
with atypical glandular cells (AGC) identified during cervical Papanicolau (Pap) smear …

Objective: To determine whether the cytologic diagnosis of atypical glandular cells of
undetermined significance (AGUS) on Pap smear was associated with a clinically significant …